SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Trypanosomiasis - Pipeline Review, H2 2013 Research Report

[February 07, 2014]

Research and Markets: Trypanosomiasis - Pipeline Review, H2 2013 Research Report

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/z239dh/trypanosomiasis) has announced the addition of the "Trypanosomiasis - Pipeline Review, H2 2013" report to their offering.

'Trypanosomiasis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Trypanosomiasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Trypanosomiasis.

Scope

- A snapshot of the global therapeutic scenario for Trypanosomiasis.

- A review of the Trypanosomiasis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.


- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Trypanosomiasis pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:

Introduction

Trypanosomiasis Overview

Therapeutics Development

Pipeline Products for Trypanosomiasis - Overview

Pipeline Products for Trypanosomiasis - Comparative Analysis

Trypanosomiasis - Therapeutics under Development by Companies

Trypanosomiasis - Therapeutics under Investigation by Universities/Institutes

Trypanosomiasis - Pipeline Products Glance

Early Stage Products

Trypanosomiasis - Products under Development by Companies

Trypanosomiasis - Products under Investigation by Universities/Institutes

Trypanosomiasis - Companies Involved in Therapeutics Development

Trypanosomiasis - Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Target (News - Alert)

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Assessment by Therapeutic Class

Drug Profiles

Subunit Vaccine For Trypanosomiasis - Drug Profile

Xenomycin - Drug Profile

Cysteine Proteases Inhibitors - Drug Profile

Drug For Parasitic Diseases - Drug Profile

Nitrobenzyl Phosphoramide Mustards - Drug Profile

Trypanosomiasis - Recent Pipeline Updates

Companies Mentioned

iBio, Inc.

Panacela Labs, Inc.

For more information visit http://www.researchandmarkets.com/research/z239dh/trypanosomiasis

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy